Polysomnographic Phenotypes of Obstructive Sleep Apnea and Incident Type 2 Diabetes Results from the DREAM Study

被引:14
|
作者
Ding, Qinglan [1 ]
Qin, Li [2 ]
Wojeck, Brian [3 ,4 ]
Inzucchi, Silvio E. [3 ,4 ]
Ibrahim, Ahmad [4 ]
Bravata, Dawn M. [5 ,6 ]
Strohl, Kingman P. [7 ]
Yaggi, Henry K. [4 ,8 ]
Zinchuk, Andrey, V [4 ]
机构
[1] Purdue Univ, Coll Hlth & Human Sci, W Lafayette, IN 47907 USA
[2] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA
[3] Yale Sch Med, Sect Endocrinol, New Haven, CT USA
[4] Yale Sch Med, Dept Internal Med, 300 Cedar St,TAC 455SE, New Haven, CT 06520 USA
[5] Richard Roudenbush VA Med Ctr, Dept Internal Med, Indianapolis, IN USA
[6] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[7] Case Western Reserve Univ, Sect Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA
[8] VA Connecticut Healthcare Syst, Vet Affairs Clin Epidemiol Res Ctr, West Haven, CT USA
基金
美国国家卫生研究院;
关键词
incident type 2 diabetes; sleep apnea; phenotype; polysomnography; risk prediction; PERIODIC LIMB MOVEMENTS; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; OXYGEN DESATURATION; GLUCOSE-INTOLERANCE; INSULIN-RESISTANCE; VASCULAR-DISEASE; SEVERITY; IMPACT;
D O I
10.1513/AnnalsATS.202012-1556OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Obstructive sleep apnea (OSA) is associated with cardiovascular disease and incident type 2 diabetes (T2DM). Seven OSA phenotypes, labeled on the basis of their most distinguishing polysomnographic features, have been shown to be differentially associated with incident cardiovascular disease. However, little is known about the relevance of polysomnographic phenotypes for the risk of T2DM. Objectives: To assess whether polysomnographic phenotypes are associated with incident T2DM and to compare the predictive value of baseline polysomnographic phenotypes with the Apnea-Hypopnea Index (AHI) for T2DM. Methods: The study included 840 individuals without baseline diabetes from a multisite observational U.S. veteran cohort who underwent OSA evaluation between 2000 and 2004, with follow-up through 2012. The primary outcome was incident T2DM, defined as no diagnosis at baseline and a new physician diagnosis confirmed by fasting blood glucose >126 mg/dL during follow-up. Relationships between the seven polysomnographic phenotypes (1. mild, 2. periodic limb movements of sleep [PLMS], 3. non-rapid eye movement and poor sleep, 4. rapid eye movement and hypoxia, 5. hypopnea and hypoxia, 6. arousal and poor sleep, and 7. combined severe) and incident T2DM were investigated using Cox proportional hazards regression and competing risk regression models with and without adjustment for baseline covariates. Likelihood ratio tests were conducted to compare the predictive value of the phenotypes with the AHI. Results: During a median follow-up period of 61 months, 122 (14.5%) patients developed incident T2DM. After adjustment for baseline sociodemographics, fasting blood glucose, body mass index, comorbidities, and behavioral risk factors, hazard ratios among persons with "hypopnea and hypoxia" and "PLMS" phenotypes as compared with persons with "mild" phenotype were 3.18 (95% confidence interval [CI], 1.53-6.61] and 2.26 (95% CI, 1.06-4.83) for incident T2DM, respectively. Mild OSA (5 <= AHI < 15) (vs. no OSA) was directly associated with incident T2DM in both unadjusted and multivariable-adjusted regression models. The addition of polysomnographic phenotypes, but not AHI, to known T2DM risk factors greatly improved the predictive value of the computed prediction model. Conclusions: Polysomnographic phenotypes "hypopnea and hypoxia" and "PLMS" independently predict risk of T2DM among a predominantly male veteran population. Polysomnographic phenotypes improved T2DM risk prediction comared with the use of AHI.
引用
收藏
页码:2067 / 2078
页数:12
相关论文
共 50 条
  • [41] A scalable method of determining physiological endotypes of sleep apnea from a polysomnographic sleep study
    Finnsson, Eysteinn
    Olafsdottir, Gudrun H.
    Loftsdottir, Dagmar L.
    Jonsson, Sigurdur A. E.
    Helgadottir, Halla
    Agustsson, Jon S.
    Sands, Scott A.
    Wellman, Andrew
    SLEEP, 2021, 44 (01)
  • [42] Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
    Wojeck, Brian S.
    Inzucchi, Silvio E.
    Neeland, Ian J.
    Mancuso, James P.
    Frederich, Robert
    Masiukiewicz, Urszula
    Cater, Nilo B.
    McGuire, Darren K.
    Cannon, Christopher P.
    Yaggi, Henry Klar
    SLEEP AND BREATHING, 2023, 27 (02) : 669 - 672
  • [43] Prevalence of Type 2 Diabetes in Patients with Obstructive Sleep Apnea in a Multi-Ethnic Sample
    Mahmood, Kamran
    Akhter, Natasha
    Eldeirawi, Kamal
    Onal, Ergun
    Christman, John W.
    Carley, David W.
    Herdegen, James J.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2009, 5 (03): : 215 - 221
  • [44] Nocturnal Hypoxemia Causes Hyperglycemia in Patients With Obstructive Sleep Apnea and Type 2 Diabetes Mellitus
    Hui, Peilin
    Zhao, Lijun
    Xie, Yuping
    Wei, Xiaoquan
    Ma, Wei
    Wang, Jinfeng
    Hou, Yiping
    Ning, Jing
    Zhou, Liya
    Guo, Qian
    Zhou, Shuhong
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (02) : 160 - 168
  • [45] Association between obstructive sleep apnea severity and endothelial dysfunction in patients with type 2 diabetes
    Bironneau, Vanessa
    Goupil, Francois
    Ducluzeau, Pierre Henri
    Le Vaillant, Marc
    Abraham, Pierre
    Henni, Samir
    Dubois, Severine
    Paris, Audrey
    Priou, Pascaline
    Meslier, Nicole
    Sanguin, Claire
    Trzepizur, Wojciech
    Andriantsitohaina, Ramaroson
    Martinez, Maria Carmen
    Gagnadoux, Frederic
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [46] SUBJECTIVE ESTIMATES OF SLEEP DIFFER FROM POLYSOMNOGRAPHIC MEASUREMENTS IN OBSTRUCTIVE SLEEP-APNEA PATIENTS
    MCCALL, WV
    TURPIN, E
    REBOUSSIN, D
    EDINGER, JD
    HAPONIK, EF
    SLEEP, 1995, 18 (08) : 646 - 650
  • [47] Impaired Glucose Metabolisms of Patients with Obstructive Sleep Apnea and Type 2 Diabetes
    Zhang, Ye
    Xing, Yanpeng
    Yuan, Haibo
    Gang, Xiaokun
    Guo, Weiying
    Li, Zhuo
    Wang, Guixia
    JOURNAL OF DIABETES RESEARCH, 2018, 2018
  • [48] The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes
    Shaw, Jonathan E.
    Punjabi, Naresh M.
    Naughton, Matthew T.
    Willes, Leslee
    Bergenstal, Richard M.
    Cistulli, Peter A.
    Fulcher, Greg R.
    Richards, Glenn N.
    Zimmet, Paul Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (04) : 486 - 492
  • [49] The Effect of Type-2 Diabetes Mellitus on Sleep Architecture and Sleep Apnea Severity in Patients With Obstructive Sleep Apnea Syndrome
    Durak, Busra
    Gurkan, Canan Gunduz
    Ozol, Duygu
    Sarac, Sema
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [50] Slow-wave sleep and obstructive sleep apnea in patients with type 2 diabetes mellitus
    So-Hyun Ahn
    Miji Lee
    Bon Jeong Ku
    Jeong Lan Kim
    Sleep and Breathing, 2022, 26 : 793 - 801